Compare CMPS & SSMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPS | SSMR |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United Kingdom | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2020 | 2026 |
| Metric | CMPS | SSMR |
|---|---|---|
| Price | $14.22 | $17.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $25.38 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 231.3K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.82 | $12.51 |
| 52 Week High | $15.40 | $19.61 |
| Indicator | CMPS | SSMR |
|---|---|---|
| Relative Strength Index (RSI) | 57.80 | 57.94 |
| Support Level | $13.07 | $15.98 |
| Resistance Level | $14.87 | $19.61 |
| Average True Range (ATR) | 0.65 | 1.22 |
| MACD | -0.09 | -0.15 |
| Stochastic Oscillator | 66.30 | 54.06 |
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.